Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Experimental & Molecular Medicine
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. experimental & molecular medicine
  3. articles
  4. article
The apolipoprotein E genotyping using the PCR-RFLP was useful to linkage analysis of Alzheimer's disease families
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 01 September 1997

The apolipoprotein E genotyping using the PCR-RFLP was useful to linkage analysis of Alzheimer's disease families

  • Moon Ju Oh1,
  • Eun Kee Chung EK,
  • Young Min Shin,
  • Kyung Ok Lee &
  • …
  • Young Suk Park 

Experimental & Molecular Medicine volume 29, pages 161–164 (1997)Cite this article

  • 4475 Accesses

  • 7 Citations

  • Metrics details

Abstract

Apolipoprotein E (ape E) has three common alleles (ape ε 2, ε 3 and ε 4) that code for three major isoforms E2, E3 and E4. The isoforms differ from each other by a single amino acid substitutions at two positions and also differ in their binding affinity for the apo E receptors. Moreover, recently a strong association between the apo ε 4 allele and late-onset Alzheimer disease (AD) was demonstrated. In this study, were analyzed the apo E genotypes using the Hhal digestion of PCR amplified samples, and the apo ε 4 allele frequency from 70 AD patients and 106 normal population in Korea. The results suggested that the frequency of ε 4 allele among the AD patients (35.7%) was 3 times higher than that among the control population (13.7%). The data, which are in agreement with recent reports, suggests that the apo ε 4 allele is associated with AD in Korea.

Similar content being viewed by others

Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer’s disease in the Chinese population: a meta-analysis

Article Open access 10 August 2022

Multifaceted roles of APOE in Alzheimer disease

Article 21 June 2024

Regional analysis of APOE polymorphism in Alzheimer’s disease in Spain

Article Open access 28 April 2025

Article PDF

Author information

Authors and Affiliations

  1. Department of Genetic Analysis, Seoul Clinical Laboratories (SCL), Seoul Medical Science Institute, Seoul, 140-230, Korea

    Moon Ju Oh

Authors
  1. Moon Ju Oh
    View author publications

    Search author on:PubMed Google Scholar

  2. Eun Kee Chung EK
    View author publications

    Search author on:PubMed Google Scholar

  3. Young Min Shin
    View author publications

    Search author on:PubMed Google Scholar

  4. Kyung Ok Lee
    View author publications

    Search author on:PubMed Google Scholar

  5. Young Suk Park
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Oh, M., Chung EK, E., Shin, Y. et al. The apolipoprotein E genotyping using the PCR-RFLP was useful to linkage analysis of Alzheimer's disease families. Exp Mol Med 29, 161–164 (1997). https://doi.org/10.1038/emm.1997.24

Download citation

  • Published: 01 September 1997

  • Issue date: 01 September 1997

  • DOI: https://doi.org/10.1038/emm.1997.24

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Alzheimer's disease (AD)
  • apolipoprotein E genotype
  • polymerase chain reaction-restriction fragment length polymorphism

This article is cited by

  • The TOMM40 ‘523’ polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson’s disease

    • Megan C. Bakeberg
    • Madison E. Hoes
    • Ryan S. Anderton

    Scientific Reports (2021)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Sign up for alerts
  • RSS feed

About the journal

  • Special Feature
  • Journal Information
  • About the Editors
  • About the Partner
  • Contact
  • For Advertisers
  • Press Releases
  • Open Access Fees and Funding

Publish with us

  • For Authors & Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Experimental & Molecular Medicine (Exp Mol Med)

ISSN 2092-6413 (online)

ISSN 1226-3613 (print)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited